September 18, 2018 - Rochester, NY and Tampa, FL - iuvo BioScience is proud to announce, in support of the continued growth of the business, the following professionals joining the organization.

Combined expertise and experience creates fully integrated, research to release, ophthalmic development services company.

July 9, 2018 - Rush, New York and Tampa, Florida – iuvo BioScience, an industry leading R&D services company specializing in safety, microbiology, toxicology, and analytical chemistry testing for the medical device and pharmaceutical industries, announced today that it has added Oculos Clinical Research, a leader in ophthalmic clinical research, to its corporate organization.

June 29, 2018 – RUSH, NY - iuvo BioScience is proud to announce that, in a span of two weeks, the company hosted and passed re-accreditation inspections from the following agencies and for the following standards:

June 12, 2018 – As iuvo recently wrapped up its 2018 United Way Campaign, iuvo’s Chief Scientific Officer Mary Richardson received a Shining Star award from the United Way of Greater Rochester in recognition for her commitment and leadership to this program.

April 16, 2018 – iuvo BioScience’s Chief Scientific Officer Dr. Mary Richardson will be presenting on ophthalmic drug products considerations for E&L studies at the Product Quality Research Institute Extractables and Leachables Workshop this week.

April 9, 2018 - Iuvo BioScience will be attending the Ophthalmology Innovation Summit (OIS) on April 12, 2018 at The Renaissance Washington, in Washington, DC. 

March 2, 2018 - iuvo BioScience will be attending the 57th Annual Meeting and ToxExpo for the Society of Toxicology, March 11-15, 2018.

The meeting will be held at the Henry B. Gonzalez Convention Center in San Antonio, Texas. 

iuvo will be represented by Dr. Kathleen Krenzer and John Lanzafame.  Please stop by our booth (number 1433) in the exhibit hall if you are attending, or feel free to send us an This email address is being protected from spambots. You need JavaScript enabled to view it..

We look forward to seeing you there!

NOVEMBER 15, 2017 - Dr. Kathleen Krenzer, iuvo BioScience’s Research Fellow in Toxicology, was recently chosen as the Vice President-Elect of the Ocular Toxicity Specialty Section of the Society of Toxicology.

November 8, 2017 - iuvo BioScience is proud to announce that our Chief Scientific Officer, Dr. Mary Richardson, was named a finalist for the 2018 ATHENA Awards.  The ATHENA Awards are presented by the Greater Rochester Chamber of Commerce and is awarded annually to a professional female leader who has demonstrated achievements in business, community service and the professional advancement of women.

NOVEMBER 5, 2017 - iuvo BioScience announced today that iuvo’s President and CEO Ben Burton was named to the Board of Directors of MedTech at the MedTech 2017 Annual Meeting.